Resource August 15, 2017 Implications for Managed Care Pharmacy from the FDA Reauthorization Act of 2017 (FDARA) AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars. Generic Drugs, Government/Legal Affairs, Legislation & Regulation
